These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 17565629)

  • 21. Nonalcoholic fatty liver disease: hepatic manifestation of obesity and the metabolic syndrome.
    Boppidi H; Daram SR
    Postgrad Med; 2008 Jul; 120(2):E01-7. PubMed ID: 18654060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Should nonalcoholic fatty liver disease be treated differently in elderly patients?
    Suzuki A; Diehl AM
    Nat Clin Pract Gastroenterol Hepatol; 2005 May; 2(5):208-9. PubMed ID: 16265200
    [No Abstract]   [Full Text] [Related]  

  • 23. Nonalcoholic fatty liver disease: a challenge for pediatricians.
    Widhalm K; Ghods E
    Int J Obes (Lond); 2010 Oct; 34(10):1451-67. PubMed ID: 20838401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease.
    Schindhelm RK; Diamant M; Dekker JM; Tushuizen ME; Teerlink T; Heine RJ
    Diabetes Metab Res Rev; 2006; 22(6):437-43. PubMed ID: 16832839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Albuminuria predicting outcome in diabetes: incidence of microalbuminuria in Asia-Pacific Rim.
    Weir MR
    Kidney Int Suppl; 2004 Nov; (92):S38-9. PubMed ID: 15485414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Non-alcoholic fatty liver disease can cause permanent liver damage].
    Kechagias S; Ekstedt M
    Lakartidningen; 2012 Nov 14-20; 109(46):2100-4. PubMed ID: 23259217
    [No Abstract]   [Full Text] [Related]  

  • 27. Hepatocellular carcinoma and non-alcoholic fatty liver disease: Major liver diseases emerging from the Asia-Pacific Region.
    Ishii H
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):6-7. PubMed ID: 16706801
    [No Abstract]   [Full Text] [Related]  

  • 28. Non-alcoholic fatty liver disease and metabolic syndrome: what we know and what we don't know.
    Akbar DH; Kawther AH
    Med Sci Monit; 2006 Jan; 12(1):RA23-6. PubMed ID: 16369477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Current trends of NASH/NAFLD in Asia-Pacific region].
    Ishii H
    Nihon Rinsho; 2006 Jun; 64(6):1017-9. PubMed ID: 16768103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of non-alcoholic fatty liver disease].
    Koek GH
    Ned Tijdschr Geneeskd; 2011; 155():A3181. PubMed ID: 21649947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review article: diagnosis and treatment of non-alcoholic fatty liver disease.
    Oh MK; Winn J; Poordad F
    Aliment Pharmacol Ther; 2008 Sep; 28(5):503-22. PubMed ID: 18532991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of patients with non-alcoholic fatty liver disease: current views and perspectives.
    Federico A; Trappoliere M; Loguercio C
    Dig Liver Dis; 2006 Nov; 38(11):789-801. PubMed ID: 16750661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonalcoholic fatty liver disease.
    Bayard M; Holt J; Boroughs E
    Am Fam Physician; 2006 Jun; 73(11):1961-8. PubMed ID: 16770927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Non-alcoholic fatty liver--life of overindulgence with fatty liver].
    Füessl HS
    MMW Fortschr Med; 2005 Jun; 147(25):4-6, 8. PubMed ID: 16038330
    [No Abstract]   [Full Text] [Related]  

  • 35. Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients.
    Manousou P; Kalambokis G; Grillo F; Watkins J; Xirouchakis E; Pleguezuelo M; Leandro G; Arvaniti V; Germani G; Patch D; Calvaruso V; Mikhailidis DP; Dhillon AP; Burroughs AK
    Liver Int; 2011 May; 31(5):730-9. PubMed ID: 21457446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-alcoholic steatohepatitis in children.
    Nanda K
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between nonalcoholic fatty liver disease and metabolic syndrome.
    Chen SH; He F; Zhou HL; Wu HR; Xia C; Li YM
    J Dig Dis; 2011 Apr; 12(2):125-30. PubMed ID: 21401898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The liver and the waistline: Fifty years of growth.
    Farrell GC
    J Gastroenterol Hepatol; 2009 Oct; 24 Suppl 3():S105-18. PubMed ID: 19799688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic syndrome and NASH.
    Marchesini G; Marzocchi R
    Clin Liver Dis; 2007 Feb; 11(1):105-17, ix. PubMed ID: 17544974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors.
    St George A; Bauman A; Johnston A; Farrell G; Chey T; George J
    J Gastroenterol Hepatol; 2009 Mar; 24(3):399-407. PubMed ID: 19067776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.